Zimmer Biomet
1,030 hedge funds and large institutions have $29.9B invested in Zimmer Biomet in 2021 Q1 according to their latest regulatory filings, with 96 funds opening new positions, 329 increasing their positions, 348 reducing their positions, and 71 closing their positions.
131% more call options, than puts
Call options by funds: $125M | Put options by funds: $54.3M
35% more first-time investments, than exits
New positions opened: 96 | Existing positions closed: 71
8% more funds holding in top 10
Funds holding in top 10: 13 → 14 (+1)
5% more capital invested
Capital invested by funds: $28.4B → $29.9B (+$1.47B)
2% more funds holding
Funds holding: 1,012 → 1,030 (+18)
0.63% more ownership
Funds ownership: 91.59% → 92.21% (+0.63%)
5% less repeat investments, than reductions
Existing positions increased: 329 | Existing positions reduced: 348
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
+$267M |
| 2 |
BlackRock
New York
|
+$244M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
+$193M |
| 4 |
Bank of New York Mellon
New York
|
+$158M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$134M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$909M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$155M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$105M |
| 4 |
SIC
Schwartz Investment Counsel
Plymouth,
Michigan
|
-$66.2M |
| 5 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
-$62M |
ZBH Hedge Fund Activity: Q1 2021 in Review
1,030 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q1 2021, worth a combined $29.9B — up 5.2% from $28.4B a quarter earlier.
Buyers outnumbered sellers: 96 funds opened new ZBH positions and 71 closed out — a net gain of 25 holders — while 329 added to existing stakes and 348 trimmed.
The largest buyer was Capital International Investors, adding an estimated $267M. The largest seller was Massachusetts Financial Services, cutting an estimated $909M.
- 1,030 institutional investors held Zimmer Biomet (ZBH) as of Q1 2021, up from 1,012 in Q4 2020.
- Funds reported $29.9B of Zimmer Biomet stock for Q1 2021, up 5.2% quarter-over-quarter.
- 96 funds opened new Zimmer Biomet positions in Q1 2021 and 71 closed out, a net change of +25 holders.
- The largest Zimmer Biomet buyer in Q1 2021 was Capital International Investors, an estimated $267M added.
- The largest Zimmer Biomet seller in Q1 2021 was Massachusetts Financial Services, an estimated $909M sold.
Based on aggregated 13F filings for Q1 2021.